Brought to you by

Allergan licenses Merz's memantine for ophthalmic use
13 Jul 1999
Executive Summary
Allergan has received an exclusive worldwide license to ophthalmic uses of Merz's (central nervous system drugs) memantine.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com